June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Activation of canonical Wnt signaling pathway inhibits dexamethasone-induced glucocorticoid receptor signaling in the trabecular meshwork
Author Affiliations & Notes
  • Chenna Kesavulu Sugali
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Naga Pradeep Rayana
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • jiannong dai
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Michael Peng
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Sherri L Harris
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Hannah Christine Webber
    Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, United States
  • Shaohui Liu
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Stephan Dixon
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Priyanka Parekh
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Elizabeth Martin
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Louis B Cantor
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Abbot F Clark
    Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, United States
  • VijayKrishna Raghunathan
    Basic Sciences, University of Houston, Houston, Texas, United States
  • Weiming Mao
    Ophthalmology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Footnotes
    Commercial Relationships   Chenna Sugali, None; Naga Rayana, None; jiannong dai, None; Michael Peng, None; Sherri Harris, None; Hannah Webber, None; Shaohui Liu, None; Stephan Dixon, None; Priyanka Parekh, None; Elizabeth Martin, None; Louis Cantor, None; Abbot Clark, None; VijayKrishna Raghunathan, None; Weiming Mao, None
  • Footnotes
    Support  NEI 1R01EY026962 (W.M.) and Showalter Scholarship (W.M.)
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 485. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chenna Kesavulu Sugali, Naga Pradeep Rayana, jiannong dai, Michael Peng, Sherri L Harris, Hannah Christine Webber, Shaohui Liu, Stephan Dixon, Priyanka Parekh, Elizabeth Martin, Louis B Cantor, Abbot F Clark, VijayKrishna Raghunathan, Weiming Mao; Activation of canonical Wnt signaling pathway inhibits dexamethasone-induced glucocorticoid receptor signaling in the trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 2021;62(8):485.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dexamethasone (Dex) is frequently used to treat inflammation. Though Dex has many advantages, it has side effects including elevated intraocular pressure (IOP) and glaucoma. About 40% of general population may develop ocular hypertension (OHT) upon prolonged glucocorticoid treatment which is due to damages in the trabecular meshwork (TM). This type of secondary glaucoma is called glucocorticoid-induced glaucoma (GIG). Identifying the key molecules responsible for glucocorticoid-induced OHT and GIG is crucial since they can be used to develop novel glucocorticoids without causing side effects. Our published studies using perfusion cultured bovine eyes suggested that inhibition of the canonical Wnt signaling pathway promotes glucocorticoid-induced OHT and glucocorticoid responsiveness. Therefore, we hypothesize that activation of canonical Wnt signaling prevents the side effects of glucocorticoids.

Methods : Aqueous humor and TM tissues were collected from patients and donor eyes for analyzing DKK1 expression using ELISA and immunofluorescence, respectively. Luciferase assays were performed in GTM3 and NTM5 cells using the GRE or TCF reporter kit to study the activity of the glucocorticoid receptor (GR) signaling or Wnt signaling pathway. Primary human TM (HTM) cells were treated with or without Dex, Wnt3a and/or GSK3β inhibitors, and whole cell lysates and conditional medium were used for western immunoblotting (WB).

Results : We found elevated canonical Wnt signaling inhibitor Dkk1 in the aqueous humor and TM of glaucoma patients. At signaling level, we found that Dkk1 positively regulated GR signaling. We also observed that Wnt signaling activators decreased GR signaling in HTM cells using luciferase assays. Similarly, activation of GR signaling inhibited Wnt signaling. At protein level, Dex-induced extracellular matrix (ECM) was inhibited by Wnt activation using Wnt activators or Dkk1 knockdown in primary HTM cells. In contrast, inhibition of canonical Wnt signaling by β-catenin knockdown increased Dex-induced ECM proteins. At physiological level, we found that adenovirus-mediated Wnt3a expression decreased Dex-induced OHT in mouse eyes.

Conclusions : Wnt and GR signaling inhibit each other in the TM, and canonical Wnt signaling activators have the potential to prevent the side effect of glucocorticoids.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×